Cullinan Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Hold |
2,300
| – | – | 0.09% | 116 |
|
|
2026
Q1 | $1.13M | Hold |
2,300
| – | – | 0.09% | 116 |
|
|
2025
Q4 | $1.33M | Hold |
2,300
| – | – | 0.09% | 119 |
|
|
2025
Q3 | $1.12M | Hold |
2,300
| – | – | 0.07% | 128 |
|
|
2025
Q2 | $933K | Hold |
2,300
| – | – | 0.06% | 130 |
|
|
2025
Q1 | $1.14M | Hold |
2,300
| – | – | 0.08% | 123 |
|
|
2024
Q4 | $1.2M | Hold |
2,300
| – | – | 0.08% | 125 |
|
|
2024
Q3 | $1.37M | Hold |
2,300
| – | – | 0.08% | 126 |
|
|
2024
Q2 | $1.27M | Hold |
2,300
| – | – | 0.07% | 133 |
|
|
2024
Q1 | $1.34M | Hold |
2,300
| – | – | 0.08% | 135 |
|
|
2023
Q4 | $1.22M | Sell |
2,300
-400
| -15% | -$194K | 0.07% | 138 |
|
|
2023
Q3 | $1.37M | Hold |
2,700
| – | – | 0.08% | 133 |
|
|
2023
Q2 | $1.41M | Hold |
2,700
| – | – | 0.08% | 143 |
|
|
2023
Q1 | $1.56M | Sell |
2,700
-400
| -13% | -$225K | 0.09% | 134 |
|
|
2022
Q4 | $1.71M | Hold |
3,100
| – | – | 0.09% | 127 |
|
|
2022
Q3 | $1.57M | Buy |
3,100
+100
| +3% | +$56K | 0.1% | 126 |
|
|
2022
Q2 | $1.63M | Buy |
3,000
+1,600
| +114% | +$881K | 0.1% | 120 |
|
|
2022
Q1 | $827K | Hold |
1,400
| – | – | 0.04% | 152 |
|
|
2021
Q4 | $934K | Buy |
1,400
+600
| +75% | +$375K | 0.05% | 144 |
|
|
2021
Q3 | $457K | Hold |
800
| – | – | 0.03% | 185 |
|
|
2021
Q2 | $404K | Buy |
800
+200
| +33% | +$94.4K | 0.02% | 184 |
|
|
2021
Q1 | $274K | Buy |
+600
| New | +$286K | 0.02% | 192 |
|
|
2018
Q2 | – | Sell |
-22,170
| Closed | -$4.58M | – | 184 |
|
|
2018
Q1 | $4.58M | Buy |
22,170
+360
| +2% | +$75.6K | 0.35% | 84 |
|
|
2017
Q4 | $4.14M | Sell |
21,810
-285
| -1% | -$54.6K | 0.3% | 88 |
|
|
2017
Q3 | $4.18M | Sell |
22,095
-3,385
| -13% | -$613K | 0.32% | 82 |
|
|
2017
Q2 | $4.45M | Sell |
25,480
-2,900
| -10% | -$487K | 0.35% | 80 |
|
|
2017
Q1 | $4.36M | Buy |
28,380
+5,500
| +24% | +$841K | 0.36% | 73 |
|
|
2016
Q4 | $3.23M | Buy |
22,880
+1,100
| +5% | +$162K | 0.27% | 97 |
|
|
2016
Q3 | $3.46M | Buy |
21,780
+3,270
| +18% | +$504K | 0.3% | 91 |
|
|
2016
Q2 | $2.73M | Sell |
18,510
-3,720
| -17% | -$549K | 0.22% | 99 |
|
|
2016
Q1 | $3.15M | Buy |
22,230
+3,200
| +17% | +$429K | 0.27% | 93 |
|
|
2015
Q4 | $2.7M | Sell |
19,030
-9,350
| -33% | -$1.25M | 0.24% | 94 |
|
|
2015
Q3 | $3.47M | Buy |
28,380
+160
| +0.6% | +$20.8K | 0.32% | 73 |
|
|
2015
Q2 | $3.66M | Buy |
28,220
+150
| +0.5% | +$19.6K | 0.3% | 78 |
|
|
2015
Q1 | $3.77M | Buy |
+28,070
| New | +$3.62M | 0.29% | 73 |
|
Other funds holding TMO
Cullinan Associates's TMO Position: Q2 2026 in Review
Cullinan Associates held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,300 shares worth $1.15M. The position accounts for 0.09% of the portfolio, ranked #116.
Cullinan Associates first reported a position in TMO in Q1 2015 and has held it in 35 quarters since. The position peaked at $4.58M in Q1 2018. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cullinan Associates held 2,300 shares of Thermo Fisher Scientific worth $1.15M as of Q2 2026.
- Cullinan Associates left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.09% of Cullinan Associates's portfolio in Q2 2026, its #116 holding.
- Cullinan Associates first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 35 quarters since.
- Cullinan Associates's Thermo Fisher Scientific position peaked at $4.58M in Q1 2018.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.